Phase 2b Rodatristat Study Initiated for PAH

On March 6, 2021, biopharmaceutical company Altavant Sciences ("Altavant") shared that it had initiated its Phase 2b ELEVATE 2 clinical trial. During the trial, researchers will evaluate rodatristat ethyl ("rodatristat")…

Continue Reading Phase 2b Rodatristat Study Initiated for PAH